Dr. Paul Michael Barr, MD

Dr. Barr practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Barr's NPI, 1407946460, was assigned on October 13, 2006. Dr. Barr graduated from Northeast Ohio Medical University in 2000. Dr. Barr holds New York license 257275-1.

Dr. Barr's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Barr's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Dr. Barr is also affiliated with URochester Jones Memorial Hospital. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Barr to 1 more medical group, named with a free account. Dr. Barr's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barr practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Barr's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Barr is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Barr's licenses on file in 2 states: New York and Ohio.

Dmand AI lists chronic leukemia, lymphoma and multiple myeloma among the conditions Dr. Barr treats.

CMS data shows 468 Medicare services from Dr. Barr across 7 procedure codes in 2024, for 145 Medicare patients. Medicare paid $29,182 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 145 Medicare patients who saw Dr. Barr in 2024. The largest group is 65 to 74, with 74 patients. 64% of them have high blood pressure, and 56% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barr's median patient age at 72, with 41% women.

In 2024, Dr. Barr wrote 286 Medicare Part D claims for 70 patients. 28% of them were for generic drugs. CMS names the drug for 225 of them, across 7 drugs with 11 or more claims each, at $2,459,894 in total drug cost. In 2023, CMS named 239 claims across 7 drugs.

Dr. Barr accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Barr as offering telehealth.

Dmand AI links 229 papers to Dr. Barr, published from 2010 to 2025. 2019 was the busiest year, with 30. The most frequent topics are Leukemia, Lymphocytic, Chronic, B-Cell, Antineoplastic Combined Chemotherapy Protocols and Piperidines. Dr. Barr has published most often in Blood. Dr. Barr's most frequent co-authors are Clive S. Zent, MD, John C. Byrd, MD and Bruce David Cheson, MD.

Dmand AI links Dr. Barr to 25 clinical trials, 8 of them phase 3 studies. 15 are still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, B-Cell and Lymphoma, Follicular. National Cancer Institute (NCI) sponsors the most, 10. Open Payments lists research payments to Dr. Barr that name 3 trials.

CMS Open Payments shows 205 general payments to Dr. Barr from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. AstraZeneca Pharmaceuticals LP paid the most, $23,732. It also lists 7 research payments totaling $146,441 from 2016 to 2023, naming 3 clinical trials.

Dmand AI lists 8 awards for Dr. Barr, most recently CMS Stage 1 EHR in 2012.

Dr. Barr graduated from Northeast Ohio Medical University in 2000. Dr. Barr is a member of ASCO and ASH.

Dr. Barr is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.